As of June 30, 2026, GenIP Plc carries a market capitalization of 118.66M, placing it among publicly traded companies globally. Its enterprise value stands at 87.74M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 118.66M |
| Enterprise Value | 87.74M |
As of June 30, 2026, GenIP Plc has 25.52M shares outstanding.
| Shares Outstanding | 25.52M |
These figures are as of June 30, 2026.
| PB Ratio | 5.95 |
| P/TBV Ratio | 16.14 |
As of June 30, 2026, GenIP Plc maintains a current ratio of 1.20, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.20 |
| Quick Ratio | 0.84 |
As of the close on October 22, 2026, GenIP Plc's stock has declined approximately 87.95% over the past 52 weeks. The 50-day moving average sits at 2.85, while the 200-day moving average is 6.48.
| 52-Week Price Change | -87.95% |
| 50-Day Moving Average | 2.85 |
| 200-Day Moving Average | 6.48 |
These figures are as of June 30, 2026. Total book value stands at 19.96M, with working capital of 7.35M providing operational flexibility.
| Cash & Cash Equivalents | 30.91M |
| Net Debt | -30.91M |
| Equity (Book Value) | 19.96M |
| Book Value Per Share | 0.78 |
| Working Capital | 7.35M |
Already premium?